Harleen Kaur is a regulatory affairs and public policy researcher and lawyer practising in a Delhi-based law firm.
On this blog:
- How elements of the Indian state purchase drugs, 19 August 2021.
- Response to the Consultation Whitepaper on 'Strategy for National Open Digital Ecosystems (NODEs)', 12 July 2020.
- Legal and regulatory framework for laboratory testing in India: A case study for Covid-19, 3 July 2020.
- Information about COVID-19 in India, 13 June 2020.
- Incentive compatibility and state-level regulation in Indian drug quality, 1 June 2021.
- The rise of government-funded health insurance in India, 21 January 2019.
No comments:
Post a Comment
Please note: Comments are moderated. Only civilised conversation is permitted on this blog. Criticism is perfectly okay; uncivilised language is not. We delete any comment which is spam, has personal attacks against anyone, or uses foul language. We delete any comment which does not contribute to the intellectual discussion about the blog article in question.
LaTeX mathematics works. This means that if you want to say $10 you have to say \$10.